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Abstract
Wild-type and chimeric constructs comprising rabbit sarcoplasmic reticulum (SR) Ca2-ATPase and the N-terminal
cytoplasmic portion of yeast plasma membrane H-ATPase were expressed in yeast under control of a heat-shock regulated
promoter. The wild-type ATPase was found predominantly in endoplasmic reticulum (ER) membranes. Addition of the first
88 residues of H-ATPase to the Ca2-ATPase N-terminal end promoted a marked shift in the localization of chimeric H/
Ca2-ATPase which accumulated in a light membrane fraction associated with yeast smooth ER. Furthermore, there was a
three-fold increase in the overall level of expression of chimeric H/Ca2-ATPase. Similar results were obtained for a
chimeric Ca2-ATPase containing a hexahistidine sequence added to its N-terminal end. Both H/Ca2-ATPase and 6UHis-
Ca2-ATPase were functional as demonstrated by their ability to form a phosphorylated intermediate and undergo fast
turnover. Conversely, a replacement chimera in which the N-terminal end of SR Ca2-ATPase was replaced by the
corresponding segment of H-ATPase was not stably expressed in yeast membranes. These results indicate that the
N-terminal segment of Ca2-ATPase plays an important role in enzyme assembly and contains structural determinants
necessary for ER retention of the ATPase. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Sarcoplasmic reticulum (SR) Ca2-ATPase is an
integral membrane enzyme that transports calcium
from the cytoplasm into the reticulum lumen of
muscle cells and plays a critical role in the physiology
of muscle relaxation. Over the past 10 years, studies
on site-speci¢c mutants produced in mammalian cells
have led to signi¢cant progress in de¢ning structure-
function relationships throughout the ATPase poly-
peptide [1,2]. However, the low level of SR Ca2-
ATPase expressed in COS-1 cells has prevented the
direct measurement of hydrolytic activity and ligand-
binding constants [3,4]. Larger quantities of SR
Ca2-ATPase can be produced in the baculovirus
expression system [5]. Notwithstanding, the excessive
amount of transfected insect cells required for ligand-
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binding studies renders this expression system unsuit-
able for analyzing large numbers of mutants.
In parallel with these e¡orts, several laboratories
have worked to express SR Ca2-ATPase in yeast,
which o¡ers a powerful array of genetic and cell bio-
logical methods to dissect protein function. While it
is clear that functional SR Ca2-ATPase can be ob-
tained in yeast, quantities are limited and do not yet
permit biochemical and biophysical studies [6^8].
Furthermore, the subcellular localization of yeast-ex-
pressed SR Ca2-ATPase has been controversial in
the literature. Centeno et al. [6] have shown that SR
Ca2-ATPase expressed in yeast under control of the
GAL10 promoter accumulates in several internal
membranes. In their work, the Ca2-ATPase was
predominantly recovered in a fraction that was be-
lieved to contain plasma membranes [6], though it
failed to co-localize with the yeast plasma membrane
H-ATPase upon sucrose gradient fractionation.
When secretory vesicles were isolated from a sec-de-
¢cient strain expressing SR Ca2-ATPase, Ca2-de-
pendent ATPase activity could be measured with a
coupled enzyme assay. Thus, it was proposed that a
signi¢cant amount of the recombinant Ca2-ATPase
was trapped in secretory vesicles en route to the yeast
plasma membrane [6]. In contrast, Degand et al. [7]
recently showed by sucrose gradient fractionation
and immunogold electron microscopy that the SR
Ca2-ATPase, in this case expressed under control
of the constitutive PMA1 promoter, was mainly lo-
calized to yeast membranes derived from the endo-
plasmic reticulum (ER). The recombinant Ca2-
ATPase was functional in vivo, as demonstrated by
its ability to restore growth of mutant host cells de-
prived of the endogenous organellar Ca2-ATPase
PMR1 and PMC1 [7].
In a previous study, we have shown the expression
of SR Ca2-ATPase in yeast under control of a heat
shock-activated promoter [8]. The heat shock-in-
duced SR Ca2-ATPase appeared by immuno£uo-
rescence microscopy to be localized in yeast internal
membranes and was functional, since a detergent-
solubilized and immunoprecipitated preparation
was able to form a phosphorylated intermediate in
the presence of Ca2 and ATP [9]. In the work to be
described below, we have aimed to improve expres-
sion by constructing N-terminal chimeras between
SR Ca2-ATPase and yeast plasma membrane H-
ATPase and testing the ability of signal sequences
from the latter to direct the H/Ca2-ATPase chi-
mera to the plasma membrane. This approach was
motivated by the fact that the N-terminal sequence
from yeast H-ATPase was previously shown to be
necessary to target this enzyme to the plasma mem-
brane [10]. Two types of chimeric constructs were
devised: in one of them, the N-terminal cytoplasmic
moiety of yeast plasma membrane H-ATPase was
added to SR Ca2-ATPase immediately before the
initial methionine (additive chimeric H/Ca2-ATP-
ase). In a second construct, the N-terminal H-ATP-
ase sequence was substituted for the N-terminal moi-
ety of SR Ca2-ATPase (replacement chimeric
HvCa2-ATPase). A third construct, a SR Ca2-
ATPase chimera containing a hexahistidine motif
added to its N-terminal methionine, was tested in
parallel to observe the e¡ect of addition of an unre-
lated sequence on the stability and activity of the
Ca2-ATPase. Although the replacement chimera
was not expressed in yeast, both the additive chimera
and the hexahistidine chimera were produced at
three-fold higher levels than unmodi¢ed SR Ca2-
ATPase. In both cases, most of the chimeric protein
accumulated in a distinct light ER subcompartment,
as opposed to wild-type Ca2-ATPase, which accu-
mulated in heavy ER. Thus, the exogenous sequences
introduced in the N-terminal region did modify ER
retention determinants but were not su⁄cient to di-
rect the Ca2-ATPase chimeras to the plasma mem-
brane.
2. Materials and methods
2.1. Strains and media
Saccharomyces cerevisiae strain NY605 (MATa;
ura3-12; leu2-3,112; GAL), provided by Dr. Peter
Novick (Department of Cell Biology, Yale Univer-
sity School of Medicine), was used as the host or-
ganism for the expression of rabbit SR Ca2-ATP-
ase. Secretory-de¢cient strain SY2 (MATa; ura3-52;
leu2-3,112; his4-619; sec6-4; GAL) was used for
characterization of Ca2-ATPase expression in secre-
tory vesicles. Yeast cells were transformed by the
method of Elble [11]. Transformed NY605 cells
were selected and propagated on minimal medium
BBAMEM 77697 25-10-99 Cyaan Magenta Geel Zwart
E.M.R. Reis et al. / Biochimica et Biophysica Acta 1461 (1999) 83^9584
containing 2% glucose and supplemented with 20 mg
uracil/l. Transformed SY2 cells were selected in the
same medium additionally supplemented with 20 mg
histidine/l.
2.2. Plasmid constructions
The cloned 2991 bp cDNA from fast-twitch rabbit
SR Ca2-ATPase [12] was kindly provided by Dr.
David MacLennan (University of Toronto). Unique
restriction sites HindIII and SacI were introduced by
PCR in the 5P and 3P non-coding £anking regions of
the Ca2-ATPase gene, respectively, by standard
techniques [13]. The upstream primer used for intro-
ducing the HindIII site was 5P CC AAG CTT AAA
TTA ATA ATG GAG GCC GCG CAC TC 3P (non-
homologous sequence is underlined), which simulta-
neously introduced an A at position 33 for proper
translation initiation in yeast [14]. The HindIII-SacI
fragment containing the Ca2-ATPase cDNA was
then moved to the yeast episomal plasmid YE-
plac181 [15]. To optimize expression, a SalI-HindIII
fragment containing two in tandem copies of the
yeast heat shock element (HSE2) [16] was cloned
immediately before the 5P end of the Ca2-ATPase
cDNA, and a 650 bp fragment containing the tran-
scription termination consensus sequence from the 3P
non-coding region of the yeast PMA1 gene [17] was
cloned immediately after the 3P end of the Ca2-
ATPase cDNA. The ¢nal construct has been desig-
nated pSVA12.
Plasmid pARF1 was derived from pSVA12 and
from pPROEX-1 (Life Technologies, Gaithersburg,
MD) to generate a hexahistidine-tagged Ca2-ATP-
ase cDNA. Two rounds of PCR were performed us-
ing these plasmids as templates in order to create
appropriate restriction sites for cloning. Firstly, a
187 bp fragment obtained by PCR ampli¢cation of
vector pPROEX-1 with primers 5P ACC AAG CTT
AAA TTA ATA ATG GGT CAT CAT CAT CAT
CAT C 3P (forward) and 5P C AAG CTT GGC TGT
TTT GGC G 3P (reverse) was digested with HindIII
and cloned on a HindIII-digested pBlueScript II
(Stratagene, LaJolla, CA) giving vector pHexaHis.
Secondly, a NdeI restriction site was introduced on
the 5P end of the Ca2-ATPase coding sequence by
PCR ampli¢cation of plasmid pSVA12 with primers
5P ATC AAG CTT AAA TTA CAT ATG GAG
GCC G 3P (forward) and 5P CAG CTG CTC CCC
GAA CTC ATC C 3P (reverse). The 790 bp ampli¢ed
fragment was digested with NdeI and KpnI and
cloned on NdeI-KpnI-digested pHexaHis giving vec-
tor pHexaHis-N-ATP. Dideoxy sequencing con-
¢rmed the correct frame for the ATG translation
initiation codon followed by the sequence coding
for six histidines plus a seven amino acid spacer re-
gion and a seven amino acid site for rTEV protease
cleavage (from the pPROEX-1 vector, Life Technol-
ogies, Gaithersburg, MD) which were joined to the
amino-terminal residues from SR Ca2-ATPase.
pHexaHis-N-ATP was digested with HindIII and
StuI and the 140 bp HindIII-StuI fragment was
cloned into HindIII-StuI-digested pSVA12.
Two chimeric plasma membrane H-ATPase/SR
Ca2-ATPase constructs were obtained. In one of
them, a replacement chimeric HvCa2-ATPase, res-
idues Met1^Leu24 from Ca2-ATPase were replaced
by the ¢rst 88 residues from yeast plasma membrane
H-ATPase. To that end, the yeast PMA1 gene [18]
was used as a template for PCR ampli¢cation with
primers 5P GAA CGG AAT TCA GAA AAT CAT
TGA AAA GAA TAA GAA G 3P (forward) and 5P
CAT CGG AAT TCA GGC CTG TAG ATG GGT
CAG TTT GTA AAT ATT C 3P (reverse). The 344
bp ampli¢ed fragment contained the sequence coding
for the 88 amino acid residues of H-ATPase £anked
by an EcoRI restriction site at its 5P non-coding end
and StuI-EcoRI restriction sites at its 3P end. This
fragment was digested with EcoRI, cloned into
EcoRI-digested pBlueScript II and fully sequenced
by the dideoxy method. This construct was desig-
nated pN-PMA1. pN-PMA1 was digested with Hin-
dIII-StuI and the 292 bp HindIII-StuI fragment was
ligated to HindIII-StuI-treated pSVA12 giving plas-
mid pSVA21. A second, additive H/Ca2-ATPase
chimera was constructed by placing the ¢rst 88 res-
idues from yeast plasma membrane H-ATPase im-
mediately before Met1 of Ca2-ATPase. To that end,
plasmid pARF1 was digested with NdeI, made blunt
with Klenow and digested with HindIII to remove
the fragment containing the hexahistidine sequence.
pN-PMA1 was digested with HindIII-StuI and the
292 bp HindIII-StuI fragment was ligated to NdeI-
Klenow-HindIII-treated pARF1 giving pVVL1.
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2.3. Induction of SR Ca2+-ATPase synthesis and
isolation of membranes
Transformed yeast cells (strain NY605) were
grown at 23‡C in glucose minimal medium supple-
mented with uracil to early-log phase (OD600V0.5)
and then shifted to 37‡C for 90 min. Preparation of
cell lysates was essentially as described by Perlin et
al. [19]. Following a low speed (418Ug for 3 min)
centrifugation for removal of unbroken cells and
large debris, the lysate was sequentially spun at me-
dium speed (two times 24 000Ug for 20 min) and
high speed (135 000Ug for 1 h). The resulting pellets
were resuspended in the original volume of homoge-
nization bu¡er by use of a Potter-Elvehjem tissue
grinder and stored at 380‡C. Alternatively, the
24 000Ug pellet was resuspended at 1400 OD600/ml
in 50 mM MOPS, pH 7.5, 0.3 M sucrose, 1 mM
CaCl2 in order to concentrate the Ca2-ATPase for
functional assays. Protease inhibitors were included
in the homogenization bu¡er and in all subsequent
steps at the following concentrations: diisopropyl
£uorophosphate, 1 mM; chymostatin, 5 Wg/ml; and
leupeptin, pepstatin and aprotinin, 2 Wg/ml each.
2.4. Sucrose gradient fractionation
Yeast lysates were fractionated by sucrose gradient
centrifugation essentially as described by Antebi and
Fink [20].
2.5. Isolation of secretory vesicles
Secretory vesicles were isolated as described by
Ambesi et al. [21], using sec-de¢cient cells expressing
either wild-type Ca2-ATPase or N-tagged Ca2-
ATPase.
2.6. Protein methods and enzyme assays
Protein concentration was determined by the
method of Lowry et al. [22] using bovine serum al-
bumin as a standard. Guanosine diphosphatase was
assayed according to Abeijon et al. [23]. NADPH-
cytochrome c reductase was assayed as described by
Feldman et al. [24]. Vanadate-sensitive H-ATPase
activity was measured ad described by Nakamoto et
al. [16].
2.7. Electrophoretic and immunological methods
For Western blots, electrotransfer of proteins from
SDS gels to nitrocellulose membranes and blocking
with non-fat milk were performed according to
standard procedures [25]. Monoclonal antibody
against rabbit SR Ca2-ATPase (A52) was diluted
1:2000 and detected with the ECL-luminol kit
(Amersham-Pharmacia). For quantitative dot-blots
one of the following antibodies was used: monoclo-
nal antibody A52 (1:2000 dilution), yeast endoplas-
mic reticulum BiP/Kar2 antiserum [26] (1:5000 dilu-
tion) or a polyclonal antibody against Neurospora
crassa plasma membrane H-ATPase [27] (1:2000
dilution). Following incubation with 2 WCi protein
A-125I for 2 h, the bound antibodies were detected
by exposure to an autoradiography ¢lm (Hyper¢lm/
Amersham-Pharmacia). The relative amounts of
Ca2-ATPase, BiP/Kar2 or H-ATPase present in
each fraction, expressed in integrated optical density
units (IOD), were determined using the ImageMaster
VDS densitometer and software (Amersham-Phar-
macia). Quantitation of expressed Ca2-ATPase
was estimated by comparison with SR Ca2-ATPase
puri¢ed from rabbit muscle and spotted on the dot-
blot membranes.
2.8. Immuno£uorescence microscopy
Fixation and immuno£uorescent staining of in-
duced yeast cells were performed essentially as de-
scribed by Pringle et al. [28]. The slides were incu-
bated overnight with a mouse monoclonal antibody
against rabbit SR Ca2-ATPase (mAb Cl-30) diluted
1:30 plus rabbit polyclonal antibody against yeast
endoplasmic reticulum BiP/Kar2 diluted 1:1000.
After 2 h incubation with secondary antibodies (Sig-
ma, USA) against mouse IgG labelled with tetra-
methyl-rhodamine isothiocyanate and rabbit IgG la-
belled with £uorescein isothiocyanate (diluted 1:300),
the slides were mounted with p-phenylenediamine.
Fluorescence and di¡erential interference contrast
images were acquired using a Zeiss PlanApochro-
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matic 100U1.4 NA objective on a Zeiss Axiovert 100
microscope attached to a Bio-Rad MRC-1024 UV
confocal laser scanning system.
2.9. Immunoprecipitation of SR Ca2+-ATPase
The 24 000Ug yeast membrane fraction described
in Section 2.3 was used for detergent solubilization
and immunoprecipitation of heterologous Ca2-
ATPase as described by Skerjanc et al. [5] using
3 mg of a monoclonal antibody raised against rabbit
SR Ca2-ATPase (mAb Cl-30) and 30 Wl protein A-
Sepharose (Amersham-Pharmacia).
2.10. Phosphoenzyme formation and turnover
Phosphoenzyme formation was carried out by in-
cubation of the immunoprecipitated Ca2-ATPase in
30 Wl of phosphorylation bu¡er (50 mM MOPS, pH
6.5, 80 mM KCl, 10 mM MgCl2, 0.1 mM CaCl2,
1 mg/ml C12E8, 0.5 mg/ml asolectin) containing
10 WM [Q-32P]ATP and 100 WM CaCl2 for 10 s at
4‡C, as described by Clarke et al. [4]. The phosphor-
ylation reaction was stopped by addition of 0.5 ml
ice-cold 10% trichloroacetic acid (TCA) and acid-
washed by centrifugation as described [4]. When in-
dicated in Section 3, addition of 100 Wl of phosphor-
ylation bu¡er containing 250 WM cold ATP before
stopping the reaction with acid was performed to
determine the decay rate of phosphoenzyme inter-
mediate. Following separation by acidic SDS-
PAGE [4] the E-32P intermediate was detected by
autoradiography.
3. Results
3.1. E¡ect of N-terminal sequence tags on
SR Ca2+-ATPase expression
The ¢rst goal of this study was to ask whether
modi¢cation of the N-terminus would a¡ect the ex-
pression of SR Ca2-ATPase in yeast. To that end,
an 88 amino acid sequence from yeast PMA1 [18]
stretching from the initial methionine to the N-ter-
minal conserved consensus Gly-Leu of P-type ATP-
ases was either substituted for the 24 amino residues
of SR Ca2-ATPase (HvCa2-ATPase) or fused to
the initial methionine of SR Ca2-ATPase (H/Ca2-
ATPase). To test the e¡ect of an unrelated sequence
upon Ca2-ATPase expression, a 24 amino acid se-
quence containing a hexahistidine motif (plus a
spacer region and a protease cleavage site) was added
to the N-terminus of the SR Ca2-ATPase (6UHis-
Ca2-ATPase). The cDNAs encoding HvCa2-
ATPase, H/Ca2 ATPase and 6UHis-Ca2-ATPase
fusion proteins were cloned into pSVA12 to give
plasmids pSVA21, pVVL1 and pARF1, respectively.
NY605 cells were transformed with these plasmids,
grown at 23‡C, and shifted to 37‡C for induction.
After 2 h of incubation at 37‡C, total lysates were
analyzed by Western blotting with an anti-Ca2-
ATPase monoclonal antibody and a peroxidase-con-
jugated secondary antibody.
Both H/Ca2-ATPase and 6UHis-Ca2-ATPase
were expressed with the expected size and displayed
no signi¢cant degradation (Fig. 1, lanes H/Ca and
6UHis). Conversely, there was no detectable expres-
sion of the HvCa2-ATPase chimera (Fig. 1,
Fig. 1. Expression of N-terminal-tagged Ca2-ATPase. Total ly-
sates from induced cells expressing wild-type SR Ca2-ATPase
(WT), hexahistidine-tagged Ca2-ATPase (6UHis), additive chi-
meric H/Ca2 ATPase (H/Ca) or replacement H/Ca2 AT-
Pase (HvCa) were analyzed by Western blotting. Lysate from
yeast transformed with an empty plasmid served as a negative
control (C), and 0.5 Wg of Ca2-ATPase puri¢ed from rabbit
muscle sarcoplasmic reticulum served as a positive control (SR).
Samples of 20 Wg or 50 Wg of total yeast protein were separated
by 10% SDS-PAGE and transferred to a nitrocellulose mem-
brane. Recombinant Ca2-ATPase was detected by immunoblot
using a monoclonal antibody speci¢c for fast-twitch Ca2-ATP-
ase and a peroxidase-conjugated secondary antibody.
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HvCa). No Ca2-ATPase could be detected in the
empty plasmid control (Fig. 1, lane C), con¢rming
that the monoclonal antibody was speci¢c for re-
combinant Ca2-ATPases and did not cross-react
with endogenous yeast ATPases. Inspection of the
intensity of the bands when equal amounts of total
protein were applied in the gel suggested that the
Ca2-ATPase chimeras were expressed at a much
higher level than wild-type Ca2-ATPase produced
in the same conditions (Fig. 1, lanes WT, H/Ca
and 6UHis). Indeed, quantitative dot-blots described
in detail in Section 3.2 showed a three-fold higher
level of expression of the chimeras when compared
with wild-type Ca2-ATPase, making clear that the
electrotransfer used in the Western blot was not
quantitative.
3.2. Recovery of wild-type and chimeric Ca2+-ATPase
in yeast membrane fractions
The amount of wild-type SR Ca2-ATPase per
liter of induced yeast culture, as determined by quan-
titative dot-blotting, averaged 348 þ 58 Wg, corre-
sponding to approximately 0.3% of the protein
present in the total yeast lysate (Table 1, panel A).
Proper membrane insertion of SR Ca2-ATPase con-
structs was evaluated by the measurement of Ca2-
ATPase recovery within yeast membrane fractions
sedimenting with medium-speed (24 000Ug) or
high-speed (135 000Ug) velocities. After removal of
large cellular debris by low-speed centrifugation
(418Ug), 89% of the remaining SR Ca2-ATPase
was recovered in the 24 000Ug pellet, where it
amounted to 2% of the protein present in that frac-
tion. Further centrifugation at 135 000Ug recovered
an additional 7% of Ca2-ATPase (Table 1, panel
A).
Quantitative dot-blotting of H/Ca2-ATPase and
6UHis-Ca2-ATPase revealed that both chimeras
were expressed at an elevated level of 850 Wg/l of
yeast culture (Table 1, panels B and C), correspond-
ing to 1% of the protein present in total yeast lysate.
When 418Ug supernatants were fractionated, 61 and
53% of the remaining Ca2-ATPase was recovered in
the 24 000Ug pellet for H/Ca2-ATPase and
6UHis-Ca2-ATPase, respectively (Table 1, panels
B and C). The N-tagged Ca2-ATPase chimeras
amounted to 6^7% of the total protein present in
the 24 000Ug membrane pellet (Table 1, panels B
and C). Further centrifugation of the 24 000Ug
supernatant at 135 000Ug recovered an additional
13 and 18% of the chimeric Ca2-ATPases (Table
1, panels B and C).
Thus, the majority of both wild-type and N-termi-
nal-tagged Ca2-ATPase was recovered in the
24 000Ug pellet fraction. The addition of either
Table 1
Recovery of heterologous rabbit Ca2-ATPase on yeast membrane fractions
Fraction Yielda (Wg/l) Ca2-ATPase recovery mg of Ca2-ATPase per mg of total protein
A: wt Ca2-ATPase
Total lysate 348 þ 58 (4) ^ 0.003
S 418Ug 308 þ 34 (4) 1 0.003
P 24 000Ug 275 þ 55 (4) 0.89 0.02
P 135 000Ug 21 þ 11 (4) 0.07 0.01
B: H/Ca2-ATPase
Total lysate 854 þ 51 (2) ^ 0.01
S 418Ug 756 þ 68 (2) 1 0.01
P 24 000Ug 401 þ 55 (2) 0.61 0.07
P 135 000Ug 137 þ 17 (2) 0.13 0.03
C: 6UHis-Ca2-ATPase
Total lysate 840 þ 76 (3) ^ 0.01
S 418Ug 729 þ 95 (3) 1 0.01
P 24 000Ug 445 þ 53 (3) 0.53 0.06
P 135 000Ug 92 þ 8 (3) 0.18 0.03
aYield refers to Wg of recombinant Ca2-ATPase produced per liter of induced yeast cell culture which corresponded to approximately
700 OD600 units. Ca2-ATPase content in each fraction was determined by quantitative dot-blot using a monoclonal antibody against
rabbit Ca2-ATPase and 125I-protein A.
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Fig. 2. Distribution of rabbit Ca2-ATPase and marker enzymes on a sucrose gradient. Yeast lysates prepared from induced cells
transformed with plasmids containing the cDNA for wild-type SR Ca2-ATPase or N-tagged-Ca2-ATPase were fractionated by cen-
trifugation on a discontinuous sucrose density gradient (15^60%). Gradient fractions of 1.5 ml were collected from top (fraction 1) to
bottom (fraction 21) and assayed as described in Section 2. (A) Wild-type Ca2-ATPase (a), H/Ca2-ATPase (8), 6UHis-Ca2-
ATPase (b). (B) BiP/Kar2 (F) and NADPH-cytochrome c reductase (E) (endoplasmic reticulum markers). (C) GDPase (O) (Golgi
marker) and H-ATPase (R) (plasma membrane marker).
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H-ATPase or hexahistidine N-terminal sequences
caused a 2^3-fold increase in the amount of Ca2-
ATPase present in total yeast lysates and a three-fold
increase in the enrichment of SR Ca2-ATPase in the
24 000Ug pellet fraction (going from 2% to 7% of
total protein, see Table 1).
3.3. Localization of wild-type and chimeric
SR Ca2+-ATPase on yeast internal membranes
To determine the subcellular location of wild-type
and chimeric SR Ca2-ATPase, transformed yeast
cells were subjected to heat shock for 90 min, and
Fig. 3. Double-immuno£uorescence localization of rabbit SR Ca2-ATPase expressed in yeast. Yeast cells expressing wild-type Ca2-
ATPase (A), H/Ca2 chimeric ATPase (B) or hexahistidine-tagged Ca2-ATPase (C) were ¢xed in 4% formaldehyde, converted to
spheroplasts and immobilized on glass slides. The slides were incubated with mouse monoclonal antibody Cl-30 against SR Ca2-
ATPase (dilution 1:30) plus rabbit polyclonal antibody against yeast BiP/Kar2 endoplasmic reticulum marker (dilution 1:1000) fol-
lowed by rhodamine-conjugated anti-mouse secondary antibody (dilution 1:300) plus £uorescein-conjugated anti-rabbit secondary anti-
body (dilution 1:300). Yeast cells transformed with an empty plasmid were treated likewise and used as a negative control (D). Image
acquisition was performed on an MRC-1024 Bio-Rad confocal laser microscope. Rhodamine £uorescence is shown in red, £uorescein
is shown in green and they are superimposed on di¡erential interference contrast gray images to highlight the cell contours. Calibra-
tion bars are in Wm.
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total lysates were fractionated by equilibrium centri-
fugation through a 15^60% discontinuous sucrose
gradient. In Fig. 2, the fractionation pro¢les of
wild-type and N-tagged Ca2-ATPase (panel A)
were compared to the pro¢les of several yeast sub-
cellular markers (panels B and C). Wild-type Ca2-
ATPase co-sedimented with the ER marker
NADPH-cytochrome c reductase, both displaying
peaks in fraction 18 of the gradient (Fig. 2A,B). As
expected, the wild-type Ca2-ATPase peak displayed
a signi¢cant overlap with another ER marker, BiP/
Kar2, that exhibited its typical bimodal distribution
[29], with peaks in fractions 13 and 17 (Fig. 2B). The
ATPase was well separated from GDPase activity,
which served as a Golgi marker (Fig. 2C), but co-
sedimented with vanadate-sensitive H-ATPase ac-
tivity, a plasma membrane marker (Fig. 2C).
Curiously, both H/Ca2-ATPase- and 6UHis-
Ca2-ATPase-containing fractions exhibited a signif-
icant shift towards lighter regions of the gradient, as
compared with wild-type Ca2-ATPase. Both chime-
ras displayed a predominant peak in fraction 13 (Fig.
2A), which co-sedimented with a light fraction of the
ER marker BiP/Kar2 (Fig. 2B). A small, secondary
peak containing chimeric Ca2-ATPase was recov-
ered together with a heavy fraction of ER marker
BiP/Kar2 in fraction 17 (Fig. 2A,B).
Next, immuno£uorescence confocal laser micros-
copy was carried out to see whether the wild-type
SR Ca2-ATPase was predominantly localized in
the ER compartment or on the plasma membrane.
Induced spheroplasts were double-labeled with a
mouse anti-Ca2-ATPase monoclonal antibody and
a rabbit polyclonal antiserum raised against ER
marker BiP/Kar2. Following incubation with both
rhodamine-conjugated anti-mouse IgG and £uores-
cein-conjugated anti-rabbit IgG, a signi¢cant yellow
£uorescence signal resulting from the overlay of red
(rhodamine-labeled Ca2-ATPase) and green (£uo-
rescein-labeled BiP/Kar2) £uorescence could be de-
tected in internal organelles, with little if any labeling
at the cell periphery (Fig. 3A). This observation sug-
gests the co-localization of wild-type Ca2-ATPase
with BiP/Kar2 and is consistent with the idea that
the recombinant enzyme is located in the ER. Sub-
cellular localization of SR Ca2-ATPase chimeras
was also evaluated by immuno£uorescence confocal
laser microscopy. A stronger yellow to orange immu-
no£uorescence signal was observed in cells expressing
either H/Ca2-ATPase or 6UHis-Ca2-ATPase
when compared with cells expressing wild-type
Ca2-ATPase (Fig. 3A^C), correlating with the high-
er expression level seen by quantitative immunoblot-
ting. The distribution of ATPase was somewhat het-
erogeneous and spread over much of the cytoplasm
(Fig. 3A^C).
Expression in a secretory-de¢cient yeast strain
(SY2) was devised as a conclusive test to see whether
any SR Ca2-ATPase was able to move out of the
ER. Upon shifting to 37‡C, these cells accumulate
secretory vesicles, which can be isolated and assayed
for proteins en route to the plasma membrane [30].
In the experiment of Table 2, SY2 cells were trans-
formed with plasmids pSVA12, pVVL1 or pARF1
Table 2
Recoverya of wild-type and chimeric SR Ca2-ATPase in yeast secretory vesicles
Fraction Ca2-ATPase Plasma membrane
H-ATPase (%)
Endoplasmic reticulum
Kar2 (%)
wt H/Ca2 6UHis
IODb % IOD % IOD %
Total lysate 8 656 ^ 15 200 ^ 45 016 ^ ^ ^
Clari¢ed lysate 528 100 760 100 1 576 100 100 100
High-speed pellet 156 30 699 84 1 271 81 75 20
Secretory vesicles 43 9 167 20 277 18 56 8
Clari¢ed lysate is the supernatant of a 14 500Ug centrifugation of the total lysate and High-speed pellet is obtained by a 100 000Ug
centrifugation of the clari¢ed lysate as described in Section 2. Secretory vesicles were prepared from the high-speed pellet by sucrose
gradient fractionation according to Ambesi et al. [21].
aRecovery of Ca2-ATPase, H-ATPase and Kar2 in each step of secretory vesicle preparation was assayed by quantitative dot-blot-
ting using speci¢c monoclonal or polyclonal antibodies and 125I-protein A (see Section 2).
bIntegrated optical density units.
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and Ca2-ATPase expression was induced by a tem-
perature shift to 37‡C for 2 h. Secretory vesicles were
then isolated and assayed for Ca2-ATPase by quan-
titative dot-blotting. As summarized in Table 2, only
9% of the wild-type SR Ca2-ATPase present in the
clari¢ed lysate was recovered in the secretory
vesicles. This value is very similar to the 8% recovery
of the ER marker BiP/Kar2 and substantially lower
than the 56% recovery of plasma membrane H-
ATPase. Thus, it is likely that the trace amounts of
SR Ca2-ATPase in the secretory vesicle fraction
represent contamination with fragments of ER, and
that little if any ATPase is able to exit the ER under
the conditions of these experiments. As with wild-
type Ca2-ATPase, sec-de¢cient cells expressing ei-
ther H/Ca2-ATPase or 6UHis-Ca2-ATPase were
used to evaluate the ability of chimeric Ca2-ATPase
to exit the ER (Table 2). There was a two-fold in-
crease in the recovery of H/Ca2-ATPase and
6UHis-Ca2-ATPase in the secretory vesicles frac-
tion (18% and 20%) as compared with the wild-
type control (9%) (Table 2). It is worth mentioning
that the clari¢ed lysate supernatant prepared accord-
ing to the standard procedure for isolation of secre-
tory vesicles [21] contained only a small fraction of
the Ca2-ATPase present in the total lysate for both
wild-type and chimeric Ca2-ATPase constructs (see
Total lysate and Clari¢ed lysate in Table 2). This
indicates that most of the expressed SR Ca2-ATP-
ase was discarded within the heavy fraction that sedi-
mented at 14 500Ug when preparing the clari¢ed ly-
sate (Table 2). Thus, the overall recovery of either
wild-type or chimeric SR Ca2-ATPase in the secre-
tory vesicle fractions was quite small, corresponding
to approximately 0.5^1.1% of the total Ca2-ATPase
initially present in the crude lysates (see Total lysate
and Secretory vesicles in Table 2).
3.4. Phosphoenzyme formation and turnover of
wild-type and chimeric Ca2+-ATPase
To determine whether the chimeric Ca2-ATPase
expressed in yeast was functional, enriched mem-
branes recovered within the 24 000Ug pellet were
assayed for the ability to form the characteristic
L-aspartyl phosphate intermediate upon incubation
with [32P]ATP. For this purpose, the method of Sker-
janc et al. [5] was used, in which Ca2-ATPase is ¢rst
immunoprecipitated, then phosphorylated and sepa-
rated by acid gel electrophoresis. In the present
work, chimeric Ca2-ATPase was solubilized from
enriched yeast membrane fractions with the non-
ionic detergent C12E8 and immunoprecipitated with
anti-Ca2-ATPase monoclonal antibody and protein
A-Sepharose. Wild-type Ca2-ATPase was used as a
control in parallel (Fig. 4A). The immune complex
was able to form a phosphoenzyme intermediate
upon incubation with [Q-32P]ATP in the presence of
micromolar amounts of Ca2 (Fig. 4A, lane EP). No
band was seen in samples from control cells trans-
formed with an empty plasmid vector (Fig. 4A, lane
N). When the phosphorylated SR Ca2-ATPase was
Fig. 4. Phosphorylation and phosphoenzyme decay of wild-type
and N-terminal-tagged SR Ca2-ATPase. Yeast membrane frac-
tions enriched in recombinant SR Ca2-ATPase were prepared
from cells expressing either wild-type Ca2-ATPase (A and B),
hexahistidine-tagged Ca2-ATPase (C and D) or H/Ca2 chi-
meric ATPase (E and F) as described in Section 2. Aliquots
containing 1 mg of total protein were collected and Ca2-ATP-
ase was solubilized and immunoprecipitated as described in Sec-
tion 2. Maximal levels of phosphoenzyme intermediate (EP)
were measured (A, C and E) by reacting the immunoprecipi-
tated ATPase on ice for 10 s in a medium containing 50 mM
MOPS, pH 6.5, 80 mM KCl, 10 mM MgCl2, 0.1 mM CaCl2,
1 mg/ml C12E8, 0.5 mg/ml asolectin, 30% glycerol, 10 WM ATP
and 40 WCi [Q-32P]ATP. Reactions were stopped by addition of
10% TCA. Phosphoenzyme intermediate was detected after sep-
aration of samples on a 6% acrylamide acidic gel and exposure
to an X-ray ¢lm. Yeast cells transformed with an empty plas-
mid were used as a negative control (N). Decay of phosphoen-
zyme (B, D and F) was measured by reacting the ATPase with
radioactive ATP for 10 s as described above, followed by addi-
tion of 250 mM of non-radioactive ATP. Phosphorylation reac-
tion was stopped by addition of 10% TCA after incubation
with non-radioactive ATP for either 0, 5 or 10 s as indicated in
the ¢gure.
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chased with excess cold ATP, the phosphoenzyme
diminished in 5 s and had virtually disappeared by
10 s (Fig. 4B), indicating that it is capable of rapid
turnover. Likewise, the ability of chimeric Ca2-
ATPase to form a phosphorylated intermediate was
tested by reacting detergent-solubilized and immuno-
precipitated samples with [Q-32P]ATP. An acid-stable
phosphoenzyme intermediate was detected for both
H/Ca2-ATPase and 6UHis-Ca2-ATPase after
acid gel electrophoresis and autoradiography (Fig.
4C,E, lane EP). The rate of decay of the phosphoen-
zyme intermediate was similar to that of wild-type
ATPase, and no radioactive band was detected after
a 10 s chase with non-radioactive ATP (Fig. 4D,F).
4. Discussion
In this work, we demonstrate that the bulk of
wild-type SR Ca2-ATPase expressed in yeast under
control of a heat shock promoter accumulates in a
heavy fraction of ER membranes. The addition of
the N-terminal portion of H-ATPase to the N-ter-
minal end of SR Ca2-ATPase improved the ability
of chimeric H/Ca2-ATPase to move along the se-
cretory pathway, allowing it to accumulate in a light
ER membrane fraction (Fig. 2) which has been asso-
ciated in the literature with the smooth ER [31]. In-
terestingly, Degand et al. [7] observed in a recent
work that the wild-type SR Ca2-ATPase expressed
under control of the constitutive yeast PMA1 pro-
moter accumulated in a light fraction of yeast ER. It
is possible that the location of wild-type SR Ca2-
ATPase in distinct ER subcompartments in each
work is related to the di¡erent promoters employed.
When sec-de¢cient cells were transformed with ei-
ther the H/Ca2-ATPase or the hexahistidine-
tagged Ca2-ATPase cDNA, a two-fold increase in
the amount of chimeric ATPase was found in secre-
tory vesicles, as compared to wild-type enzyme. The
increase can be accounted for by the presence of
contaminant ER in the secretory vesicles fraction,
as seen by detection of Kar2 ER marker in this frac-
tion (Table 2).
A distinct shift was observed in the localization of
chimeric ATPase, which accumulated predominantly
in light ER, as opposed to wild-type ATPase that
accumulated in heavy ER fractions. Since this e¡ect
was seen for both H/Ca2-ATPase or the hexahis-
tidine-tagged Ca2-ATPase chimeras, a general e¡ect
of partial disruption of ER retention determinants,
rather than one exerted by a particular targeting se-
quence present in the H-ATPase N-terminal por-
tion (such as the conserved motif DDDIDALIEEL
[10,32]), is probably responsible for the increased
progression of the chimeric Ca2-ATPases along
yeast ER. Conceivably, the addition of either H-
ATPase or hexahistidine tags partially disrupts the
ER retention signals present in native SR Ca2-ATP-
ase. In this case, the chimeric Ca2-ATPases would
accumulate in additional subcompartments of yeast
ER, which may explain the remarkable three-fold
increase in the overall expression level of both chi-
meras when compared with wild-type Ca2-ATPase.
On the other hand, further progression along the
secretory pathway is limited by the presence of addi-
tional ER retention signals located elsewhere in the
Ca2-ATPase polypeptide, most likely within its ¢rst
two transmembrane segments [33]. Recently, Boxem-
baum et al. [34] have obtained strong evidence indi-
cating that the N-terminal region interacts with the
¢rst cytoplasmic loop, and eventually with the large
cytoplasmic loop, to modulate the equilibrium ki-
netics of the Na,K-ATPase. The existence of anal-
ogous interactions in the SR Ca2-ATPase could
provide the structural basis to explain the lack of
ATPase activity in a truncated Ca2-ATPase chimera
in which this domain was deleted [35].
We found that the corresponding region of yeast
plasma membrane H-ATPase could not replace the
N-terminal cytoplasmic moiety of SR Ca2-ATPase.
The lack of expression of the deleted chimera points
to the absence of functional conservation between
the N-terminal domains of these two P-type cation-
transporting ATPases. Previous ¢ndings from Sker-
janc et al. [35] demonstrated that the removal of
32 N-terminal residues produced a non-functional
ATPase but did not a¡ect Ca2-ATPase expression
and assembly in COS-1 cells. It is probable that the
removal of 24 N-terminal residues from the Ca2-
ATPase and its replacement with 88 N-terminal res-
idues of yeast H-ATPase, as done in the chimeric
HvCa2-ATPase construct, resulted in a misfolded
enzyme and prevented the stable expression in yeast.
The quantitative recovery of wild-type and chimer-
ic Ca2-ATPase in yeast membrane fractions follow-
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ing medium- and high-speed centrifugations indi-
cated that most of the recombinant Ca2-ATPase
was inserted into the membrane. Moreover, both
wild-type and chimeric Ca2-ATPases were function-
al as demonstrated by their ability to form a phos-
phorylated intermediate in the presence of ATP and
Ca2 and to undergo fast turnover. This evidence
reinforces the assumption that targeting of the re-
combinant constructs was not limited by inadequate
folding of the chimeric Ca2-ATPases. It should be
noted that a fraction containing 25^30% of the chi-
meric Ca2-ATPase was not recovered by high-speed
centrifugation and represents a portion of the ex-
pressed Ca2-ATPase that is not fully integrated in
yeast membranes.
The modi¢cation of the SR Ca2-ATPase by addi-
tion of amino-terminal tags described in this work
led to a three-fold increase in the amount of recombi-
nant protein produced in yeast and a seven-fold in-
crease in the enrichment of SR Ca2-ATPase in ER
fractions, where it amounted to 7% of the total pro-
tein. This is similar to results reported for COS-1
microsomes, where expressed SR Ca2-ATPase typi-
cally represents 5% of membrane protein [3]. Thus,
this approach may be useful to increase the yield of
P-type ATPases [36,37] or other heterologously ex-
pressed integral membrane proteins [38] that are
largely retained in the yeast ER. Additionally, the
expression of functional N-terminal-tagged SR
Ca2-ATPase constructs, such as the 6UHis-Ca2-
ATPase, paves the way for the development of a
SR Ca2-ATPase puri¢cation scheme based on met-
al-chelating a⁄nity chromatography [39^41].
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